Siltuximab effectively treated patients who experienced common adverse events after chimeric antigen receptor T-cell therapy, ...

While the use of chimeric antigen receptor (CAR) T-cell therapy has increased rapidly, the clinical benefit seen with these ...

One of the most severe manifestations of COVID-19 is Acute Respiratory Distress Syndrome (ARDS), a life ... inflammatory response known as a ‘cytokine storm’ that causes ARDS and damage ...

The addition of itacitinib to standard graft-versus-host-disease prophylaxis may reduce severe toxicities following haploidentical hematopoietic stem cell transplantation, according to results of a ...

BEIJING -- Chinese scientists have identified a cytokine produced by tumor cells ... has traditionally been considered as a metabolic syndrome induced by tumors, with nutritional support being ...

What are cytokines? “Simply put ... The patient can also get acute respiratory distress syndrome (ARDS). Heart: The immune system attacks the heart muscles, causing tachycardia, where the ...

TOPLINE: Bispecific antibodies (BsAbs) demonstrated a manageable safety profile in patients with non-Hodgkin lymphoma (NHL), with 48% prevalence of all-grade cytokine release synd ...

Odronextamab demonstrated a manageable safety profile and generated durable responses in patients with R/R DLBCL who have ...

The platform’s first candidate, INB-619, targets CD19, a key marker broadly found on B cells, which play a central role in leukemias, lymphomas, and autoimmune diseases. In preclinical models, INB-619 ...